In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance
about
Tigecycline: a review of a new glycylcycline antibioticDistribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources.Effects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjects.Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.Evaluation of a potential tigecycline-warfarin drug interaction.Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.Tigecycline: a new glycylcycline for treatment of serious infections.Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains.Streptococcus agalactiae from pregnant women: antibiotic and heavy-metal resistance mechanisms and molecular typing.Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality controlTigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience.Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.
P2860
Q28278979-6D4430E1-E8EC-4787-98ED-FBC309BA6762Q33554486-4C7BE4C7-399E-462E-8DA7-53DCFB6D6095Q33722140-A432ED1A-98AF-47A4-8415-8A256160634EQ34123811-16B99776-EB94-4417-9A58-EC79BEE6CE32Q34593514-8E31C5AE-B353-436F-A43B-0B4A8DEC2F66Q35072612-6E30F427-5ABA-4A37-8591-48A1049F4317Q36218312-E2979015-505A-454F-A106-C6BE479AA0E7Q36758570-F11868A7-3588-4D53-A18D-889662449A88Q37465643-F2133324-33AB-4A1B-A70B-1C6FB1617A52Q40585275-1FA5B193-7DEF-4B34-A99E-72A9F714F07CQ42432332-6C48856B-4333-47CF-AD39-0B2D44791F41Q46226514-18FC9C05-71EB-4BC9-9069-DA8A21DE4F7DQ46226517-368D616A-E636-4440-A1AF-0ED5223D6479
P2860
In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
In vitro activities of tigecyc ...... de and tetracycline resistance
@ast
In vitro activities of tigecyc ...... de and tetracycline resistance
@en
type
label
In vitro activities of tigecyc ...... de and tetracycline resistance
@ast
In vitro activities of tigecyc ...... de and tetracycline resistance
@en
prefLabel
In vitro activities of tigecyc ...... de and tetracycline resistance
@ast
In vitro activities of tigecyc ...... de and tetracycline resistance
@en
P2093
P2860
P1476
In vitro activities of tigecyc ...... de and tetracycline resistance
@en
P2093
Culebras E
Rodríguez-Avial I
Sánchez BA
P2860
P304
P356
10.1128/AAC.48.1.323-325.2004
P407
P577
2004-01-01T00:00:00Z